This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment

Authoring team

This disorder is typically resistant to treatment (1).

  • local treatments used in this condition include:
    • emollients - cooling applications such as 0.5% menthol in aqueous cream
    • oral antihistamines taken at night to reduce pruritus and allow sleep
    • topical steroid creams - may be applied occlusion
    • coal tar ointment as steroid alternative
    • other local treatments that have been used in this condition include:
      • calcipotriol ointment
      • capsaicin cream
      • pulsed dye laser
      • topical tacrolimus 0.1% has been shown to be effective in a case report (1)
      • cryotherapy - thought to cause destruction of sensory nerves and impairment of nerve regeneration
  • systemic treatments used in this condition include:
    • ciclosporin has been reported to be successful in managing nodular prurigo when administered orally (2)
    • thalidomide
    • phototherapy (UVB and PUVA)
    • naltrexone has been reported to have a high antipruritic effect in patients with prurigo nodularis (4)

Reference:

  1. Edmonds EV et al. Nodular prurigo responding to topical tacrolimus. Br J Dermatol. 2004 Jun;150(6):1216-7
  2. Woo PN et al. Br J Dermatol. 2000 Jul;143(1):215-6.
  3. Berth-Jones J, Smith SG, Graham-Brown RAC. Nodular prurigo responds to cyclosporin. Br J Dermatol 1995; 132: 795–9.
  4. Lee MR, Shumack S. Prurigo nodularis: a review. Australas J Dermatol. 2005 Nov;46(4):211-18

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.